Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):200-3. doi: 10.1016/j.ijrobp.2010.11.023. Epub 2011 Jan 14.

Abstract

Purpose: To evaluate the primary Gleason grade (GG) in Gleason score (GS) 7 prostate cancers for risk of non-organ-confined disease with the goal of optimizing radiotherapy treatment option counseling.

Methods: One thousand three hundred thirty-three patients with pathologic GS7 were identified in the Duke Prostate Center research database. Clinical factors including age, race, clinical stage, prostate-specific antigen at diagnosis, and pathologic stage were obtained. Data were stratified by prostate-specific antigen and clinical stage at diagnosis into adapted D'Amico risk groups. Univariate and multivariate analyses were performed evaluating for association of primary GG with pathologic outcome.

Results: Nine hundred seventy-nine patients had primary GG3 and 354 had GG4. On univariate analyses, GG4 was associated with an increased risk of non-organ-confined disease. On multivariate analysis, GG4 was independently associated with seminal vesicle invasion (SVI) but not extracapsular extension. Patients with otherwise low-risk disease and primary GG3 had a very low risk of SVI (4%).

Conclusions: Primary GG4 in GS7 cancers is associated with increased risk of SVI compared with primary GG3. Otherwise low-risk patients with GS 3+4 have a very low risk of SVI and may be candidates for prostate-only radiotherapy modalities.

MeSH terms

  • Aged
  • Analysis of Variance
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading*
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Organ Size
  • Prostate / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / ethnology
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / radiotherapy
  • Risk*
  • Seminal Vesicles / pathology*

Substances

  • Prostate-Specific Antigen